KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Shares Issued (2018 - 2025)

Progyny (PGNY) has disclosed Shares Issued for 8 consecutive years, with $229000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued changed N/A to $229000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 million, a N/A change, with the full-year FY2025 number at $1.1 million, up 4.09% from a year prior.
  • Shares Issued was $229000.0 for Q4 2025 at Progyny, down from $256000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $1.7 million in Q1 2023 to a low of -$978000.0 in Q4 2022.
  • A 5-year average of $514647.1 and a median of $539000.0 in 2021 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: tumbled 261.75% in 2021, then skyrocketed 333.94% in 2023.
  • Progyny's Shares Issued stood at -$406000.0 in 2021, then tumbled by 140.89% to -$978000.0 in 2022, then skyrocketed by 230.57% to $1.3 million in 2023, then crashed by 105.72% to -$73000.0 in 2024, then surged by 413.7% to $229000.0 in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Shares Issued are $229000.0 (Q4 2025), $256000.0 (Q1 2025), and -$73000.0 (Q3 2024).